Emmaus Life Sciences, Inc.(EMMA)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-09-18 | Lim Seah H. Director | Purchase | +20,000 | +9.64%227,500 | $0.04 | $800 | View SEC filing | |
| 2024-02-29 | LEE WILLIS C Co-President & COO | Purchase | +115,200 | +7.64%1,622,742 | $0.13 | $14,694 | View SEC filing | |
| 2024-01-03 | LEE WILLIS C COO | Purchase | +121,000 | +8.73%1,507,542 | $0.13 | $15,285 | View SEC filing | |
| 2023-12-21 | Lim Seah H. Director | Sale | -32,500 | -13.54%207,500 | $0.05 | $1,625 | View SEC filing | |
| 2023-12-19 | Lim Seah H. Director | Mixed | +133,200 | +345.97%171,700 | $0.22 | $31,576 | View SEC filing | |
| 2023-12-04 | LEE WILLIS C COO | Purchase | +15,609 | +1.14%1,386,542 | $0.13 | $2,023 | View SEC filing | |
| 2023-06-02 | LEE WILLIS C COO | Purchase | +29,450 | +10.19%318,324 | $0.29 | $8,533 | View SEC filing | |
| 2023-01-20 | ZEN Wei Peu Director | Purchase | +2,000,000 | +87.79%4,278,048 | $0.50 | $1,000,000 | View SEC filing | |
| 2022-12-01 | Niihara Yutaka Chairman and CEO | Purchase | +52,600 | +0.39%13,399,866 | $0.40 | $21,225 | View SEC filing | |
| 2022-11-03 | Niihara Yutaka Chairman and CEO | Purchase | +27,500 | +0.23%11,988,257 | $0.44 | $11,975 | View SEC filing | |
| 2022-10-31 | Niihara Yutaka Chairman and CEO | Purchase | +69,400 | +0.58%11,960,757 | $0.28 | $19,288 | View SEC filing | |
| 2022-10-24 | Niihara Yutaka Chairman and CEO | Purchase | +65,000 | +0.55%11,891,357 | $0.17 | $11,300 | View SEC filing | |
| 2022-10-19 | Niihara Yutaka Chairman and CEO | Purchase | +45,000 | +0.38%11,826,357 | $0.19 | $8,700 | View SEC filing | |
| 2022-10-17 | Niihara Yutaka Chairman and CEO | Purchase | +97,500 | +0.83%11,781,357 | $0.18 | $17,200 | View SEC filing | |
| 2022-10-13 | Niihara Yutaka Chairman and CEO | Purchase | +165,000 | +1.43%11,683,857 | $0.08 | $13,250 | View SEC filing | |
| 2022-10-12 | Niihara Yutaka Chairman and CEO | Purchase | +185,000 | +1.63%11,518,857 | $0.11 | $20,370 | View SEC filing | |
| 2022-07-25 | LEE WILLIS C COO | Purchase | +3,200 | +1.13%286,974 | $0.39 | $1,248 | View SEC filing | |
| 2022-06-03 | LEE WILLIS C Director & COO | Purchase | +5,000 | +1.79%283,774 | $0.39 | $1,925 | View SEC filing | |
| 2022-06-02 | Niihara Yutaka Chairman and CEO | Purchase | +7,000 | +0.06%11,333,857 | $0.49 | $3,450 | View SEC filing | |
| 2022-05-19 | Niihara Yutaka Chairman and CEO | Purchase | +23,351 | +0.21%11,326,857 | $0.41 | $9,573 | View SEC filing | |
| 2022-04-12 | LEE WILLIS C Director & COO | Purchase | +15,100 | +2.99%519,968 | $0.89 | $13,514 | View SEC filing | |
| 2022-03-02 | Niihara Yutaka Chairman and CEO | Purchase | +53,800 | +0.48%11,303,506 | $1.49 | $80,162 | View SEC filing | |
| 2022-02-28 | LEE WILLIS C Vice Chairman & COO | Purchase | +21,100 | +4.34%506,768 | $1.49 | $31,463 | View SEC filing | |
| 2022-02-28 | Niihara Yutaka Chairman and CEO | Purchase | +16,500 | +0.15%11,249,706 | $1.42 | $23,485 | View SEC filing | |
| 2022-02-23 | Niihara Yutaka Chairman and CEO | Purchase | +19,300 | +0.17%11,233,206 | $1.44 | $27,777 | View SEC filing |
1-25 of 204